The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case identification, specimen retrieval, and data preparation from the Southern Community Cohort Study. The goal is to identify biomarkers for early detection of liver cancer, which aligns with the program's focus on transforming healthcare for service members and the public through innovative biomedical research.
Generated 5/14/24, 1:46 AM